SCHEMBL24310071

SCHEMBL24310071

CCc1c(Oc2ccc(N3CCNCC3)cc2)nc(N[S+]([O-])c2cnn(C)c2)nc1-c1ccccc1C

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LCK P06239 1/20 0.35
▸ JAK3 P52333 1/20 0.35
▸ BTK Q06187 1/20 0.35
▸ TNK2 Q07912 1/20 0.35
▸ LTA4H P09960 4/20 0.35
▸ IGF1R P08069 2/20 0.32
▸ HTR7 P34969 2/20 0.32
▸ HTR1A P08908 1/20 0.32
▸ ACVR1 Q04771 4/20 0.32
▸ RET P07949 2/20 0.32
▸ CCNA2 P20248 2/20 0.32
▸ CDK2 P24941 2/20 0.32
▸ CCND3 P30281 2/20 0.32
▸ CCNB2 O95067 1/20 0.32
▸ CCNE2 O96020 1/20 0.32
▸ CDK1 P06493 1/20 0.32
▸ CDK4 P11802 1/20 0.32
▸ CCNB1 P14635 1/20 0.32
▸ CCND1 P24385 1/20 0.32
▸ CCNE1 P24864 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24310038 0.92 TNK2 (0.35) LCKJAK3BTKTNK2LTA4H
SCHEMBL24310110 0.91 RET (0.33) LCKJAK3BTKTNK2LTA4H
SCHEMBL24310067 0.83 HTR6 (0.37) LCKJAK3BTKTNK2LTA4H
SCHEMBL29567089 0.83 HTR6 (0.37) LCKJAK3BTKTNK2LTA4H
SCHEMBL24309503 0.81 KDM5A (0.34) JAK3IGF1R
SCHEMBL24310186 0.79 CTSC (0.35) JAK3TNK2IGF1RCCNA2CDK2
SCHEMBL24309589 0.79 EGFR (0.34) JAK3TNK2IGF1REGFR
SCHEMBL24310025 0.78 TNK2 (0.35) LCKJAK3BTKTNK2LTA4H
SCHEMBL24310024 0.78 LCK (0.36) LCKJAK3BTKTNK2LTA4H
SCHEMBL29567116 0.78 LCK (0.36) LCKJAK3BTKTNK2LTA4H

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback